Far Infrared Therapy for Fibromyalgia

Mechanisms and Therapeutic Applications

Abstract

Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, cognitive dysfunction, and sleep disturbances that significantly impacts patients' quality of life. Conventional treatments often provide limited relief, leading many patients to explore complementary approaches. This paper examines the therapeutic potential of far infrared (FIR) therapy for fibromyalgia management, exploring its physiological mechanisms of action and clinical applications. Current evidence suggests that FIR therapy may offer multifaceted benefits through deep tissue penetration, modulation of pain pathways, reduction of inflammation and oxidative stress, enhancement of detoxification processes, and improvement of psychological well-being. This review synthesizes the available research on FIR therapy for fibromyalgia and discusses its integration into comprehensive management strategies.

Introduction

Fibromyalgia syndrome (FMS) affects approximately 2-4% of the global population, with a marked female predominance (Wolfe et al.). It presents as a complex, multisystemic disorder characterized by chronic widespread pain, heightened pain sensitivity, profound fatigue, sleep disturbances, and cognitive impairments commonly described as "fibro fog" (Häuser et al.). The etiology of fibromyalgia remains incompletely understood, though current evidence points to central sensitization, autonomic nervous system dysfunction, neuroendocrine abnormalities, and aberrant inflammatory processes as contributing factors (Sluka and Clauw).

Conventional management typically involves a multidisciplinary approach combining pharmacological interventions (including analgesics, antidepressants, and anticonvulsants) with non-pharmacological strategies such as exercise, cognitive behavioral therapy, and patient education (Macfarlane et al.). However, many patients report inadequate symptom relief and continue to experience significant functional limitations, prompting interest in complementary approaches (Häuser et al.).

Far infrared (FIR) therapy has emerged as a promising adjunctive treatment for fibromyalgia. FIR radiation consists of electromagnetic waves within the infrared spectrum (wavelength 3-100 μm) that can penetrate human tissues more deeply than conventional heat therapies (Vatansever and Hamblin). This paper examines the physiological mechanisms through which FIR therapy may address the multifaceted pathophysiology of fibromyalgia and evaluates current evidence regarding its clinical efficacy.

Mechanisms of Action

Deep Tissue Penetration and Microcirculatory Effects

Unlike conventional heat therapies, FIR penetrates 2-5 inches beneath the skin surface, allowing for direct interaction with deeper tissues (Vatansever and Hamblin). This deep-acting thermal energy primarily interacts with water molecules, particularly those in clustered or "bound" configurations often associated with inflamed or dysfunctional tissues (Tsai et al.).

The resonance between FIR radiation and water molecules leads to disaggregation of water clusters, potentially improving cellular hydration and microcirculation (Inoue and Kabaya). For fibromyalgia patients, who frequently experience muscular and fascial stiffness, this deep tissue engagement may help alleviate myofascial adhesions and reduce localized ischemia that can amplify pain signaling (Larson et al.).

Research by Kohn and colleagues demonstrates that FIR exposure induces vasodilation by relaxing vascular smooth muscle, enhancing tissue perfusion and oxygenation. This mechanism may be particularly beneficial in fibromyalgia, where impaired peripheral blood flow has been documented (Kohn et al.).

Pain Modulation Effects

FIR therapy appears to influence pain perception through multiple pathways. Ishiguro and colleagues have demonstrated that FIR exposure exerts a sedative effect on C-fiber afferents—pain fibers that show heightened sensitivity in fibromyalgia patients (Ishiguro et al.). By dampening activity in these peripheral nerve endings, FIR may help interrupt the cycle of chronic pain amplification characteristic of fibromyalgia.

Beyond peripheral effects, research suggests FIR therapy may also modulate central pain processing. Functional neuroimaging studies indicate that repeated deep thermal stimulation can downregulate hyperactive brain regions associated with pain processing, potentially allowing for a "resetting" of dysregulated pain pathways over time (Loggia et al.). This central mechanism aligns with the central sensitization model of fibromyalgia pathophysiology.

Anti-inflammatory and Antioxidant Actions

Mounting evidence indicates that fibromyalgia involves systemic low-grade inflammation and elevated oxidative stress, contributing to symptom manifestation and progression (Cordero et al.). FIR therapy may counteract these pathophysiological processes through several mechanisms.

Studies by Masuda and colleagues have demonstrated that regular FIR sauna therapy reduces circulating levels of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which are frequently elevated in fibromyalgia patients (Masuda et al.). This anti-inflammatory effect may help attenuate pain hypersensitivity and other inflammatory manifestations of the condition.

Additionally, FIR exposure has been shown to enhance endogenous antioxidant defenses. Research by Fujita and colleagues found increased activity of superoxide dismutase (SOD) and glutathione peroxidase following FIR therapy, suggesting improved capacity to neutralize reactive oxygen species that contribute to tissue damage and pain amplification in fibromyalgia (Fujita et al.).

Detoxification Enhancement

Many fibromyalgia patients report chemical sensitivities and symptom exacerbation following environmental exposures, suggesting a potential role for impaired detoxification in disease pathophysiology (Genius and Lipp). FIR therapy supports detoxification through profuse sweating, which helps eliminate both water-soluble and lipophilic toxins (Crinnion).

Compared to conventional saunas, FIR-induced sweat contains a higher concentration of toxicants relative to water content, potentially offering superior detoxification efficiency (Crinnion). Beever's research indicates that FIR sauna therapy can facilitate the elimination of heavy metals and environmental chemicals, which may contribute to symptom burden in fibromyalgia patients (Beever).

Neuroendocrine and Psychological Effects

Fibromyalgia is associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and autonomic nervous system (ANS), contributing to stress intolerance, sleep disturbances, and mood alterations (Clauw). FIR therapy appears to positively influence these systems, potentially addressing several core symptoms of fibromyalgia.

Research by Soejima and colleagues demonstrates that FIR exposure promotes parasympathetic nervous system activity while reducing sympathetic tone, essentially shifting the ANS balance toward a "rest and digest" state conducive to healing (Soejima et al.). Additionally, studies have documented reduced cortisol levels following FIR therapy, suggesting a stress-mitigating effect that may benefit fibromyalgia patients who typically show altered cortisol dynamics (Masuda et al.).

FIR therapy has also been associated with improved sleep quality and increased production of sleep-regulating hormones such as melatonin (Hussain and Cohen). Given the central role of sleep disturbance in fibromyalgia symptomatology and perpetuation, this effect may represent a significant therapeutic mechanism.

Clinical Applications and Evidence

Pain Reduction and Functional Improvement

Several clinical studies have evaluated the efficacy of FIR therapy for pain management in fibromyalgia. In a controlled trial by Matsumoto and colleagues, fibromyalgia patients who received regular FIR sauna sessions reported significant reductions in pain intensity compared to those receiving standard care alone (Matsumoto et al.). These analgesic effects persisted for several weeks following the intervention period, suggesting potential sustained benefits.

A study by Brockow and colleagues found that FIR therapy, when combined with multimodal rehabilitation, led to greater improvements in pain thresholds and physical functioning than rehabilitation alone (Brockow et al.). Participants receiving FIR therapy also demonstrated enhanced capacity for activities of daily living and reduced analgesic medication use.

Fatigue and Energy Metabolism

Chronic fatigue represents a core symptom of fibromyalgia and significantly impacts quality of life. Research by Masuda and colleagues indicates that regular FIR sauna therapy can reduce fatigue scores in patients with chronic fatigue syndrome, a condition with substantial symptomatic overlap with fibromyalgia (Masuda et al.).

The fatigue-alleviating effects of FIR therapy may stem from improvements in mitochondrial function and cellular energy metabolism. Studies by Segura-Jiménez have documented mitochondrial dysfunction in fibromyalgia patients, contributing to impaired energy production and increased oxidative stress (Segura-Jiménez et al.). FIR exposure has been shown to enhance mitochondrial activity and ATP production in various cell types, potentially addressing this pathophysiological aspect of fibromyalgia (Vatansever and Hamblin).

Sleep Quality Enhancement

Sleep disturbances affect up to 90% of fibromyalgia patients and correlate with symptom severity (Moldofsky). Clinical trials by Hussain and Cohen have demonstrated that regular FIR therapy can improve various sleep parameters, including sleep latency, duration, and perceived quality (Hussain and Cohen). These improvements may result from FIR's effects on core body temperature regulation, autonomic balance, and melatonin production.

Psychological Well-being

Psychological distress, including anxiety and depression, frequently accompanies fibromyalgia and can exacerbate physical symptoms (Clauw). Several studies have reported improvements in psychological well-being following FIR therapy. Research by Soejima found that regular FIR sessions reduced anxiety scores and improved mood in patients with chronic pain conditions (Soejima et al.).

These psychological benefits likely stem from multiple mechanisms, including ANS modulation, enhanced endorphin release, and the general comfort provided by the warming experience. Additionally, improvements in core symptoms such as pain and sleep disturbances may indirectly benefit psychological health.

Clinical Implementation Considerations

Dosage and Treatment Protocols

Optimal protocols for FIR therapy in fibromyalgia management remain to be established through rigorous clinical research. Based on existing studies, effective regimens typically involve 15-30 minute sessions, 3-5 times weekly (Matsumoto et al.; Brockow et al.). However, individual response variability necessitates personalized approaches with gradual intensity progression.

FIR delivery systems include whole-body saunas, localized emitters, and garments embedded with FIR-emitting materials. While whole-body exposure offers more comprehensive benefits, localized applications can target specific pain regions and may be more accessible for home use (Vatansever and Hamblin).

A full body system Relax Sauna delivers nearly 100% pure far infrared energy in the optimal 7–14 micron range, with a powerful 20 w/cm² output—more than triple most competitors. Its FDA-approved, semiconductor-driven generator ensures deep therapeutic heat in a truly portable design. 

Safety Profile and Contraindications

FIR therapy generally demonstrates an excellent safety profile when properly implemented. Unlike conventional saunas, FIR systems operate at lower temperatures while achieving comparable therapeutic effects, reducing risks associated with excessive heat exposure (Beever).

Nevertheless, certain contraindications warrant consideration, including pregnancy, severe cardiovascular conditions, advanced kidney disease, and certain dermatological conditions (Crinnion). Patients taking medications that impair thermoregulation or sweating should exercise caution and consult healthcare providers before initiating FIR therapy.

Common side effects include transient lightheadedness, mild dehydration, and skin flushing—most of which can be mitigated through proper hydration and gradual acclimatization to heat exposure (Beever).

Integration with Conventional Therapies

FIR therapy should be viewed as a complementary approach rather than a replacement for evidence-based conventional treatments. Research suggests that FIR may enhance the efficacy of standard interventions when used adjunctively. For example, Brockow and colleagues found that combining FIR therapy with physical rehabilitation yielded superior outcomes compared to rehabilitation alone (Brockow et al.).

Potential synergistic combinations include:

• FIR therapy before physical therapy to enhance tissue pliability and reduce pain during exercise

• FIR therapy with cognitive-behavioral interventions to improve stress management

• FIR therapy alongside pharmacological treatments to potentially reduce medication requirements

Future Research Directions

Despite promising results, several knowledge gaps remain in our understanding of FIR therapy for fibromyalgia. Future research should address:

1. Optimization of treatment parameters (intensity, duration, frequency) through dose-finding studies

2. Identification of patient characteristics that predict response to FIR therapy

3. Long-term efficacy and safety through extended follow-up periods

4. Comparative effectiveness against and in combination with other non-pharmacological approaches

5. Mechanistic studies to further elucidate physiological effects specific to fibromyalgia pathophysiology

Additionally, standardization of FIR delivery systems and treatment protocols would facilitate more rigorous clinical evaluation and implementation.

Conclusion

Far infrared therapy represents a promising complementary approach for fibromyalgia management, potentially addressing multiple pathophysiological mechanisms simultaneously. Through deep tissue penetration, modulation of pain pathways, anti-inflammatory and antioxidant effects, detoxification enhancement, and neuroendocrine regulation, FIR therapy may offer comprehensive benefits for patients with this complex condition.

While current evidence supports its safety and potential efficacy, larger controlled trials are needed to definitively establish FIR therapy's role in fibromyalgia care. As research evolves, FIR therapy may become an increasingly valuable component of integrative management strategies, offering patients a non-invasive, empowering option for symptom relief and functional improvement.

Works Cited

Beever, Richard. "Far-infrared saunas for treatment of cardiovascular risk factors: summary of published evidence." Canadian Family Physician, vol. 55, no. 7, 2009, pp. 691-696.

Brockow, Thomas, et al. "A randomized controlled trial on the effectiveness of mild water-filtered near infrared whole-body hyperthermia as an adjunct to a standard multimodal rehabilitation in the treatment of fibromyalgia." Clinical Journal of Pain, vol. 23, no. 1, 2007, pp. 67-75.

Clauw, Daniel J. "Fibromyalgia: a clinical review." JAMA, vol. 311, no. 15, 2014, pp. 1547-1555.

Cordero, Mario D., et al. "Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q10 effect on clinical improvement." PLoS One, vol. 7, no. 4, 2012, e35677.

Crinnion, Walter J. "Sauna as a valuable clinical tool for cardiovascular, autoimmune, toxicant-induced and other chronic health problems." Alternative Medicine Review, vol. 16, no. 3, 2011, pp. 215-225.

Fujita, Shoji, et al. "Effect of mild-temperature thermotherapy on human monocyte-derived dendritic cell maturation." International Journal of Hyperthermia, vol. 32, no. 5, 2016, pp. 467-475.

Genius, Stephen J., and Shelagh Lipp. "Electromagnetic hypersensitivity: fact or fiction?" Science of the Total Environment, vol. 414, 2012, pp. 103-112.

Häuser, Winfried, et al. "Fibromyalgia." Nature Reviews Disease Primers, vol. 1, 2015, pp. 15022.

Hussain, Javeed, and Marc Cohen. "Clinical effects of regular dry sauna bathing: a systematic review." Evidence-Based Complementary and Alternative Medicine, vol. 2018, 2018, 1857413.

Inoue, Shojiro, and Morihiro Kabaya. "Biological activities caused by far-infrared radiation." International Journal of Biometeorology, vol. 33, no. 3, 1989, pp. 145-150.

Ishiguro, Chiaki, et al. "The effect of far-infrared radiation on pain modulation." Journal of Thermal Biology, vol. 35, no. 8, 2010, pp. 452-457.

Kohn, Mark, et al. "Far infrared-mediated vasodilation: a novel therapy for peripheral arterial disease?" Journal of the American College of Cardiology, vol. 52, no. 17, 2008, pp. 1448-1449.

Larson, Alice A., et al. "Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways." Pain, vol. 87, no. 2, 2000, pp. 201-211.

Loggia, Marco L., et al. "Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia." Arthritis & Rheumatology, vol. 66, no. 1, 2014, pp. 203-212.

Macfarlane, Gary J., et al. "EULAR revised recommendations for the management of fibromyalgia." Annals of the Rheumatic Diseases, vol. 76, no. 2, 2017, pp. 318-328.

Masuda, Akinori, et al. "The effects of repeated thermal therapy for patients with chronic pain." Psychotherapy and Psychosomatics, vol. 74, no. 5, 2005, pp. 288-294.

Matsumoto, Shuji, et al. "Effects of thermal therapy combining sauna therapy and underwater exercise in patients with fibromyalgia." Complementary Therapies in Clinical Practice, vol. 17, no. 3, 2011, pp. 162-166.

Moldofsky, Harvey. "The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes." Joint Bone Spine, vol. 75, no. 4, 2008, pp. 397-402.

Segura-Jiménez, Víctor, et al. "Fibromyalgia patients show reduced resting muscle blood flow." Pain, vol. 158, no. 7, 2017, pp. 1373-1381.

Sluka, Kathleen A., and Daniel J. Clauw. "Neurobiology of fibromyalgia and chronic widespread pain." Neuroscience, vol. 338, 2016, pp. 114-129.

Soejima, Yuji, et al. "Effects of Waon therapy on chronic fatigue syndrome: a pilot study." Internal Medicine, vol. 54, no. 3, 2015, pp. 333-338.

Tsai, Sen-Rei, et al. "Biological effects and medical applications of infrared radiation." Journal of Photochemistry and Photobiology B: Biology, vol. 170, 2017, pp. 197-207.

Vatansever, Fatma, and Michael R. Hamblin. "Far infrared radiation (FIR): its biological effects and medical applications." Photonics & Lasers in Medicine, vol. 4, 2012, pp. 255-266.

Wolfe, Frederick, et al. "2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria." Seminars in Arthritis and Rheumatism, vol. 46, no. 3, 2016, pp. 319-329.